- From: Mead, Charlie (NIH/NCI) [C] <meadch@mail.nih.gov>
- Date: Wed, 15 Aug 2012 02:01:56 -0400
- To: Kerstin Forsberg <kerstin.l.forsberg@gmail.com>, HCLS hcls <public-semweb-lifesci@w3.org>
I would say Yes -- particularly since there is now an effort to represent some of newest HL7 standards -- FHIR resource definitions in particular -- using SW approaches...and the BRIDG OWL representation will almost certainly benefit from this effort. charlie ________________________________________ From: Kerstin Forsberg [kerstin.l.forsberg@gmail.com] Sent: Wednesday, August 15, 2012 1:57 AM To: HCLS hcls Subject: FDA: seeks input on Study Data Exchange Standards FDA seeks "input from industry, technology vendors, and other members of the public regarding the advantages and disadvantages of current and emerging open, consensus-based standards for the exchange of regulated study data. " In the annoncement for a meeting 5 November FDA ask for responses, before 5 October, on questions such as "- What are the advantages and disadvantages of HL7 v3 and CDISC ODM?" And, interestingly, they also ask: "- Are there other open data exchange standards that should be evaluated?" Is this an opportunity for a semantic web based proposal? Kind Regards Kerstin Forsberg AstraZeneca https://www.federalregister.gov/articles/2012/08/14/2012-19748/regulatory-new-drug-review-solutions-for-study-data-exchange-standards-notice-of-meeting-request-for
Received on Wednesday, 15 August 2012 06:04:13 UTC